logo ESICM

home

 

 

 

330 participants have now been recruited to the Trial.

 

The Eurotherm3235Trial is an international, multi-centre, randomised controlled trial which will examine the effects of titrated therapeutic hypothermia (32-35°C) as a treatment for raised intracranial pressure after traumatic brain injury. The trial will enrol 600 patients who are admitted to the Intensive Care Unit. Eligible patients will be randomised to receive either:

  • the standard care for patients following traumatic brain injury
  • standard care with therapeutic hypothermia (32-35°C).


Funding provided by:

Aug 2012 - The Eurotherm3235 Trial is funded by the National Institute of Health Research's Health Technology Assessment Programme - www.nihr.ac.uk

The internal pilot was funded by the European Society of Intensive Care Medicine – www.esicm.org

Trial Sponsor:

University of Edinburgh and NHS Lothian (UK)

All ICUs caring for TBI patients are welcome to join the Trial

 

 

Adresse Eurotherm